ABSTRACT
INTRODUCTION
A small number of in vivo engrafting (lympho-)hematopoietic stem cells (HSCs), present in bone marrow (BM), placental/umbilical cord blood (CB), or growth factor-mobilized peripheral blood stem-progenitor cells (PBSCs), give rise to progressively more lineage-committed hematopoietic progenitor cells (HPCs), which in turn produce all of the mature blood and immune cells and probably endothelial cells as well. In humans, most HSCs and HPCs express the CD34 phosphoglycoprotein protein and mRNA. In vivo-engrafting HSCs comprise Ͻ Ͻ1% of the total CD34 ϩ cell population. The CD34 ϩ / CD38
Ϫ /Lin Ϫ cell population is highly (ϳ100-fold) enriched in these in vivo-engrafting HSCs, as compared with the total CD34 ϩ cell population. Other markers such as efficient efflux pumping of rhodamine or Hoescht dyes or CD133, which enrich for primitive hematopoietic stem-progenitor cell (HSPC) subpopulations, have also been described but are much less extensively characterized for human as opposed to mouse HSPCs, with regard to HSC function such as repopulation and engraftment ability (1) (2) (3) (4) (5) .
A significant body of work has been reported on the gene expression of mouse HSPCs. For example, initial studies used cDNA/reverse transcription-PCR (RT-PCR)-based subtraction libraries of transcripts expressed in mouse fetal liver (6) or BM (7) HSPCs and found hundreds to thousands of transcripts overrepresented in HSPCs, as compared with more mature hematopoietic cells.
Park et al. (8) , using a subtractive microarray approach to compare mouse HSC-enriched Thy1.1 lo c-kit ϩ Sca-1 hi Lin -/lo cells to HPCenriched populations, found that ϳ5000 cDNA clones were differentially expressed between the two populations. Terskikh et al. (7) used nylon cDNA arrays, containing a limited set of 1176 genes, to examine gene expression of mouse HSCs, common myeloid, granulocytemacrophage, megakaryocyte-erythrocyte, and lymphoid progenitors, and pro-B, and pro-T cells. Although this study examined only a handful of genes, the authors showed that a number of hematopoiesisspecific genes were expressed by HSCs. The expression of these genes decreased in progressively more committed HPCs, which at the same time, began to express lineage-specific genes. Akashi et al. (9) performed a similar study with 24,000 gene oligonucleotide arrays. In addition to confirming the prior study, they found that HSCs expressed a number of nonhematopoietic genes. However, because of the difficulties of isolating numbers of highly purified HSC-enriched subpopulations sufficient to produce the quantities of RNA needed for microarray hybridization, to date, only a handful of studies have attempted similar gene expression analyses with human HSPCs. Instead, most previous microarray analyses of human HSPCs have had to use relatively unpurified, total CD34 ϩ cell preparations (only Ͻ Ͻ1% of which are HSCs), rather than more highly HSC-enriched subpopulations of CD34 ϩ cells. As an example, Steidl et al. (10) examined the expression of 1185 genes from BM and PBSC (total) CD34 ϩ cells. They found 65 genes differentially expressed, some of which may explain the higher levels of cell cycling in CD34 ϩ cells from BM, as compared with PBSCs. Although these studies defined genes expressed in the total CD34 ϩ cell population, these analyses may have missed expression of key human HSC genes or misinterpreted their expression in HSCs versus more mature HPCs. In other words, these studies most likely identified genes expressed principally in HPCs, not HSCs. In addition, only relatively small-scale microarray gene expression analyses have been reported (generally Ͻ5,000 -12,000 known genes), further limiting the impact of these studies of human HSPCs.
Two recent studies have begun to define a general gene expression phenotype for stem cells. Ramalho-Santos et al. (11) examined the transcriptomes of side population mouse BM Kit ϩ Lin Ϫ Sca-1 ϩ HSCenriched cells, mouse neurospheres, and a mouse embryonic stem cell line. Four transcripts were expressed in all three stem cell types but not in more mature cell types. An additional 212 transcripts were highly enriched in the three types of stem cells, but these genes were also detected in more mature cell types. Ivanova et al. (12) A total of 322 transcripts was enriched in all these HSPC populations and 283 transcripts in all three stem cell types. Interestingly, both these groups found that approximately half of the genes expressed in the stem cell-enriched populations had unknown function or were expressed sequence tags (ESTs). Yet, similar to previous work with HSPCs, these investigations studied mainly mouse cells, examining only one human cell population. In addition, comparison of the lists of stem cell-overexpressed genes from these two studies reveals that only 6 genes common to both lists (13) (14) (15) ϩϩ HPC-enriched but HSC-depleted population from each tissue source (intersection analysis), we would identify a set of genes that might include candidate regulators involved in the survival, self-renewal, differentiation, and/or migration/adhesion capacities of human HSCs, as well as genes that may be targets in cancer stem cells, which give rise to blood cancers. Our principal gene expression analysis was carried out using the Affymetrix U133 chip set, containing 45,102 individual genetic targets (including a number of known genes/transcripts, predicted genes, and ESTs). We found 81 genes that were overrepresented and 90 genes underrepresented in the CD34 ϩ /CD38 Ϫ /Lin Ϫ populations from all three tissues. To additionally confirm our comparisons and to possibly identify completely unknown transcripts and those missed by microarrays, we performed serial analysis of gene expression (SAGE; Ref. 19 -21) on the BM HSC and HPC subpopulations. SAGE confirmed expression levels of 94% of the overrepresented transcripts. In addition, SAGE detected ϳ58% more transcripts than the oligonucleotide microarrays, a large proportion of which were expressed only in the HSC-enriched population. Many of the tags detected by SAGE as overexpressed in HSC did not map to any known transcript or EST. 
MATERIALS AND METHODS

Isolation of CD34
Purification of Total RNA
After FACS, cells were pelleted by centrifugation at 800 ϫ g in RNase-free, 1.5-ml siliconized microcentrifuge tubes (Ambion, Austin, TX). Pellets were disrupted by vigorous pipeting in 100 l of Trizol Reagent (Invitrogen, Carlsbad, CA)/10 6 cells. This solution was transferred to 1.5-ml PhaseLocHeavy tubes (Eppendorf, Hamburg, Germany), 20 l of chloroform were added/100 l of Trizol, and the tubes were centrifuged at maximum speed (ϳ20,000 ϫ g) in a microcentrifuge. The aqueous phase containing RNA was removed and additionally purified using the RNeasy Mini-Kit (Qiagen, Valencia, CA) following the manufacturer's RNA Clean-up protocol with the optional On-column DNase Treatment; the only modification to the Qiagen protocols was that numbers of washes for all washing steps were doubled.
Analysis of Gene Expression
Microarray Analysis of BM, CB, and PBSCs. Five hundred ng of total RNA from each sample were double linear amplified with the ENZO BioArray High Yield RNA Transcript Labeling kit and the GeneChip Eukaryotic Small Sample Target Labeling Assay, Version II protocol (Affymetrix, Santa Clara, CA) to produce target for hybridization to Affymetrix U133 chips. Although 2ϫ linear amplification of RNA is a commonly used and reliable method, we tested the fidelity of the method in preserving relative gene expression levels. RNA from total CD34
ϩ PBSCs was compared with a reference RNA prepared from a control cell line. Five g of each RNA were tested after standard 1ϫ amplification, and 500 ng of each were tested after 2ϫ amplification by hybridization to the U133A chip. Fold change comparisons of each condition were then performed with GeneSpring 5.0.2 software (Silicon Genetics, Redwood City, CA). Although there were minor changes in the absolute magnitude of change for a small number of genes, the directionality of change was different in Ͻ0.001% of the ϳ4000 transcripts scored as "Present" (unpublished data).
BM and PBSC samples were tested in biological duplicate (i.e., samples from two different donor pools). The CB sample was tested in technical duplicate (i.e., same RNA donor pool analyzed twice). Initial quality assessments of duplicate samples were analyzed using Affymetrix MAS 5.0 software. In addition to the internal chip normalizations performed with Affymetrix chips, the U133 chips contain a set of 100 normalization genes (probe sets 200,000 -200,099), which have been shown to be stably expressed across many different cell types; these normalization genes were used for additional normalization of all samples. Genespring 5.0.2 software was used for statistical analysis of differential transcript expression. In addition to the parametric statistical measures of gene expression provided by GeneSpring 5.0.2 and Affymetrix MAS 5.0, we used the nonparametric hypothesis-based analysis of microarrays method as a secondary filter applied to the experiment in the selection of overrepresented genes (Refs. 22, 23; see supplemental text for a full explanation of hypothesis-based analysis of microarrays). Filemaker Pro 6.0 software (Filemaker, Inc., Santa Clara, CA) was used to build a gene expression database, to compare gene expression patterns, and to classify genes by functional category. Gene/transcript annotation data were obtained by query of the Unigene, 6 Locus Link, 7 On-line Mendalian Inheritance in Man, 8 and Kyoto Encyclopedia of Genes and Genomes molecular pathway information 9 databases (24) . Percent identity between cell populations was calculated by the formula: shared genes in population A and B (and C)/all genes expressed by population A or B (or C).
SAGE. Eight hundred ng of total RNA from the BM HSC-enriched and HPC-enriched populations were analyzed by Micro-SAGE. Micro-SAGE was carried out with the iSAGE kit (Invitrogen) and modified to follow the Micro-SAGE protocol (25) . Sequencing of SAGE 10-mer tags of 2304 clones from each library was carried out by Agencourt Bioscience Corporation (Beverly, MA). SAGE tags were enumerated, annotated (with both the Reliable-and Full-SAGE tag mappings; see web site for a full description of these methods), 10 and normalized with SAGE 2000 version 4.5 software (Invitrogen). Filemaker Pro 6.0 was used to build a gene expression database from the tag data. Transcripts with a SAGE tag count of 1 were excluded from analysis because erroneous tag sequences can be generated by sequencing errors at a rate of ϳ1/500 tags. Because the odds of having two identical erroneous tags detected is ϳ1/100,000 tags, we considered any gene expressed at Ն2 tags to be present by SAGE. There is no consensus statistical method (26 -29) for addressing significant differences of expression between SAGE libraries; we chose the method of Man et al. (26) to calculate P values for expression differences between the libraries.
Confirmation of Gene Expression
RNA sequences for differentially expressed transcripts were downloaded from GenBank. 11 Multiple PCR primers for each transcript were designed with Primer 3.0 (Whitehead Institute, Massachusetts Institute of Technology, Boston, MA) 12 and tested against a 2-fold dilution series of test sample prepared by mixing cDNA from unsorted CD34 ϩ cells from BM, CB, and PBSCs. We had previously determined that ␤-actin is an optimal normalization gene for calibration of quantitative RT-PCR (qRT-PCR) results among different CD34 ϩ cell populations (unpublished results). Two-step RT-PCR was carried out by first producing cDNA with a modified version of the Super-SMART PCR cDNA kit (Clontech, Palo Alto, CA). Second, qRT-PCR was carried out on a Bio-Rad iCycler (Bio-Rad, Hercules, CA) with iQ SYBR-green Supermix (Bio-Rad). Only primer sets that produced a single product band (as shown by both agarose gel and melt-curve analysis) and that resulted in doubling efficiencies of ϳ100% were used for additional analyses. This was imperative because the -⌬⌬Ct method (30) was used to calculated fold difference in gene expression.
RESULTS
CD34
؉ /CD38 Fig. S1 ) demonstrated that the purified cell populations were highly enriched for the specified phenotypes.
The Transcriptome of CD34 ؉ /CD38 ؊ /Lin ؊ Cells by Oligonucleotide Microarray Analysis. The oligonucleotide microarray gene expression results for each of the three tissues were filtered with MAS 5.0 software to select only those genes scored as "Present" in the CD34 ϩ /CD38 Ϫ /Lin Ϫ populations. A total of 11,849 transcripts was expressed by at least one of three HSC populations. A total of 6,366 transcripts was detected in the CD34 ϩ /CD38 Ϫ /Lin Ϫ population from BM, 11,075 from CB, and 6,669 from PBSCs (Fig. 1A) . A total of 
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Research. ϩϩ HPC-enriched population. These genes were also independently selected by the nonparametric, hypothesis-based analysis of microarrays method (Database S6). Functional annotation of the HSCoverrepresented genes (Fig. 2B ) yielded 50 genes of known/predicted function and 30 genes of unknown function (including 12 ESTs and 7 predicted proteins). Annotation of the HSC-underrepresented genes yielded 59 genes of known function and 31 genes of unknown function including 15 ESTs and 8 predicted proteins (Fig. 3B) .
SAGE of BM HSC-Enriched and HPC-Enriched Populations. The BM populations showed the greatest differences in gene expression between the HSC-and HPC-enriched populations. Therefore, this population was chosen for SAGE. A total of 84,107 tags was detected from the HSC population library and 87,416 tags from the HPC population library. Herein, we focused on only the genes identified as HSC-overexpressed genes by the microarray analyses. SAGE produced tags for 65 of the 81 transcripts, which were overexpressed in HSCs by microarray analysis (Table 1) . SAGE confirmed overexpression of 61 (94%) of these 65 genes found overexpressed by the HSC population. For 4 (6%) transcripts, SAGE showed similar expression in the HSC versus HPC population. SAGE did not detect nonredundant tags for 16 (20%) of the 81 transcripts (Table 1) , making it impossible to determine expression of these transcripts by SAGE.
Overall, SAGE identified 10,078 transcripts expressed by BM HSC-enriched cells (Database S7a), ϳ58% more transcripts than the 6366 detected by microarray analysis. In addition, 2916 transcripts were overexpressed at least 2-fold in the BM HSC-enriched population by SAGE (Database S7b), compared with the 1190 transcripts identified as HSC overexpressed by microarray analysis. Of these HSC-overexpressed transcripts identified by SAGE, 2008 were detected exclusively in the HSC population (i.e., they were completely absent in the HPC-enriched population). A total of 646 tags detected by SAGE as expressed in HSCs (Database S7c) did not map to any known transcript or EST; of these, 408 tags were overexpressed in HSCs, and 238 of these 408 tags were detected exclusively in the HSC-enriched population (i.e., not detected in HPCs).
Confirmation of Gene Expression Results by qRT-PCR.
Twentynine genes were chosen from the list of microarray HSC-overrepresented genes (Table 1 ) and 19 genes from the list of HSC-underrepresented (Table S4 ) genes for confirmation of fold difference by relative qRT-PCR. Transcripts were chosen to cover the entire observed range of fold differences from 2-fold to the maximum of 60-fold. Expression levels of these 48 transcripts were tested in HSCand HPC-enriched populations from all three tissues for a total of 144 independent qPCR tests. A total of 141 of these 144 qRT-PCR assays confirmed the observed differential expression in the CD34 ϩ /CD38 Ϫ / Lin Ϫ HSC-enriched compared with the CD34 ϩ /[CD38/Lin] ϩϩ HPCenriched cell population; there were only 3 transcripts where differential expression by microarray was not confirmed by qRT-PCR for all three tissues (Figs. S2A and S2B) . In each of these 3 cases, the analyses disagreed in only one tissue of the three tissues (and even in this one tissue, there was a difference in gene expression, but it did not meet the arbitrary 2-fold cutoff). Therefore, an exceptional level of 98% qRT-PCR confirmation was achieved for microarray results in Hs.355977 Unknown a BM, bone marrow; CB, cord blood; PBSC, peripheral blood stem-progenitor cell; SAGE, serial analysis of gene expression; HSC, hematopoietic stem cell; ND, not determined. b Genes marked with an asterisk (*) were confirmed by quantitative reverse transcription-PCR. c HSC denotes that SAGE tags were only detected in the HSC population and not in the HPC population. ND indicates that unique, reliable SAGE tags were not available for this transcript.
d UniGene cluster numbers are given when available. Those numbers in parenthesis indicate the GenBank accession number for those genes that have not been assigned UniGene Cluster numbers.
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on April 14, 2017. © 2004 American Association for Cancer cancerres.aacrjournals.org Downloaded from this study. Indeed, the magnitude of fold difference detected by qRT-PCR tended to be greater than those found by the microarrays for several of genes (e.g., CRFBP, LAGY, EDM, and HTM4), most likely due to greater sensitivity of PCR, and agreed very closely for most others (e.g., CD52, HERMES, HLF, and FKSG14).
DISCUSSION
To date, gene expression studies of human HSPCs have focused on either the total CD34 ϩ cell population and/or have compared purified subsets of CD34 ϩ cells from only a single tissue. Although these studies have added to the knowledge base concerning HSPCs, HSCs are only a tiny subset of the total CD34 ϩ cell population. Therefore, analyses of total CD34 ϩ cells might not detect genes expressed selectively by HSCs, especially genes expressed at relatively low levels, but would detect mostly genes expressed by committed progenitor cells. For example, in a recent investigation that analyzed the total CD34 ϩ cell population by SAGE (31), myeloperoxidase was one of the genes found to be expressed in total CD34 ϩ cells. However, myeloperoxidase is expressed only in committed phagocytic precursors and phagocytes, not in undifferentiated HSCs (32) (33) (34) .
Two problems of analyzing subpopulations of CD34 ϩ cells from a single tissue quickly become evident. First, comparisons of cells within a given tissue will probably identify not only genes important for HSC functions but also a large number of genes expressed due to the general physiology of the HSPCs residing within that particular tissue. Second, although CD34 ϩ /CD38 Ϫ /Lin Ϫ cells isolated from BM, CB, or PBSCs contain HSCs capable of fully reconstituting hematopoiesis, they are still a heterogeneous population of cells (1) (2) (3) (4) (5) , which also contains some very early HPCs. Therefore, we postulated that comparing the gene expression profiles of the purified CD34 ϩ / CD38
Ϫ /Lin Ϫ cell population to that of the CD34 ϩ /[CD38/Lin] ϩϩ population from each of these three tissues and then determining the genes identified as differentially expressed by the HSC in all three tissues (intersection analysis) would allow us to focus more clearly on genes likely to be involved in HSC versus HPC function; because all three tissue populations contain HSCs, which engraft after bone marrow transplantation, those transcripts differentially expressed in the HSC-enriched populations from all three tissues should include all transcripts vital to HSCs, whereas those genes expressed only in one tissue type, as well as those due to differences in the heterogeneous makeup of the CD34 ϩ /CD38 Ϫ /Lin Ϫ population, would tend to be filtered out.
Intersection analysis identified 4746 transcripts expressed by the HSC-enriched populations from all three tissues (Fig. 1A) . These genes encoded transcription factors, signaling/receptor proteins, and other molecules with known functions. In concordance with the observations of other stem cell studies (6 -8, 11, 12, 31) , a plurality of the HSC-expressed genes had unknown function were ESTs or encoded hypothetical proteins. Our list of genes expressed in CD34 ϩ / CD38 Ϫ /Lin Ϫ cells (Supplemental Database S2) includes a number of genes previously shown to be involved in hematopoiesis (e.g., KIT, FLT3, GATA-2, GATA-3, p27, HoxA5, and HoxA9), as well as markers for HSCs (e.g., CD34, MDR2). Many genes known (or expected) to be expressed only by HPCs or more mature blood or immune cells (e.g., myeloperoxidase, CD38) are not present in this HSC list but are detected in the HPC population (Supplemental Database S4). These indicate stringent purity of the HSC and HPC populations, which we examined, as suggested by the flow cytometric reanalysis of the purified cell populations (Fig. S1) . Genes expressed by only one population, and many of those expressed by two populations should fall within the following categories: (a) genes expressed due to tissue-specific microenvironment; (b) genes differentially expressed because of different proportions of HSCs to non-HSCs (i.e., very early progenitor) cells within the CD34 ϩ /CD38 Ϫ /Lin Ϫ population; or (c) genes falsely scored positive by the Affymetrix chip system. Intersection analysis is designed to exclude all of these conditions. We generated lists of genes that were differentially expressed (with a statistically significant 2-fold change) in the microarray analyses of the CD34 ϩ /CD38 Ϫ /Lin Ϫ versus the CD34 ϩ /[CD38/ Lin] ϩϩ population (Supplemental Databases S2 and S3). Approximately 2200 genes were differentially overexpressed by any one of the HSC populations. In contrast to these large numbers of differentially expressed genes in any single tissue, only 81 genes were overrepresented ( Fig. 2A, Table 1 ), and 90 genes were underrepresented in the intersection (Fig. 3A, Table S4 ) of HSC-enriched populations. The qRT-PCR and SAGE results provide extremely high confirmation rates, indicating that the intersection analysis was highly selective for identifying actual differentially expressed genes.
The HSC population overexpressed a number of known genes that (35) . CEBPB has been shown to control the expression of a number of cytokines in immune cells (36) and is involved in cell survival and tumorigenesis associated with the RAS oncogene (37) . The recently annotated human immune-associated nucleotide 2 protein is a putative control protein of GDP/GTP-signaling proteins (38) and may also play a role in self-renewal by limiting the effects of growth factor-directed differentiation. We found two HOX genes (39, 40) overexpressed. HoxA3 is involved in formation of the nervous system (41, 42) , pharyngeal glandular organs (43) , and thymic epithelial cells (44) but has not been studied in hematopoiesis. HoxB6 is expressed in HSPCs (45) (46) (47) , is involved in differentiation of the granulocytic lineage (48) , and may suppress development of erythroid progenitors (49) .
In addition to confirming the microarray results, SAGE results revealed three additional interesting findings. First, SAGE detected ϳ30% more genes expressed by the HSC-enriched population than were detected by microarray, most likely because of low copy number or high probe set background (the latter would cause the MAS 5.0 software to make an "Absent" call for that particular transcript). We scored a transcript tag as "Present" only if it occurred at a frequency of two tags or greater. Although unlikely, it is possible that a small number of transcripts are false positives because of sequencing errors during tag detection. In addition, it is possible that a small percentage of the detected tags identify splice variants of the same gene. A large proportion of the transcripts identified by SAGE were expressed exclusively within the HSC population, many times more than were exclusively expressed within the HPC-enriched population. This tends to confirm the observation of Terskikh et al. (7) and Akashi et al. (9) who showed that hematopoietic genes expressed by mouse HSCs diminish during differentiation to early and late HPCs, which begin to express lineage-specific genes. Our data with human populations tend to confirm this finding for the equivalent human genes, e.g., HoxA5, HoxA9, Bmi-1, RER, Tyk2, JAM1, API-1, and API-2, although a number of these genes were not differentially expressed (at Ͼ2-fold between the HSC and HPC populations) in all three tissues. Also, a current theory to explain the multipotent and possible trans-differentiation potential of stem cells is that they exist in an open epigenetic state; this would allow the stem cell to develop toward any lineage by transcriptional up-regulation of a lineage-specific set of genes without chromatin remodeling. Gene silencing would occur in maturing cells, resulting in a more restricted transcriptome. Akashi et al. (9) suggest that HSCs have an open chromatin structure because they appear to weakly express a number of genes normally associated with nonhematopoietic cell types. Our overall expression data (Fig. 1A , Supplemental Database S1) support this theory because a number of nonhematopoietic genes are detected, e.g., neuronal-associated genes ANA/ BTG3, GIF/TIEG, and SMN1; endothelial-associated genes ANG-1 and PROCR/EPCR; liver-associated genes CYP2C38, CPT1, and aldo-keto reductase 1; and muscle-associated genes MEF2 and NRAP. Furthermore, fetal CB HSCs (hypothesized to be more a more primitive population than adult BM or PBSC HSCs) expressed many more genes than adult BM or PBSC HSCs. This considerable number of additional transcripts beyond those identified by the microarrays may be involved in HSC biology. Finally, we found 646 tags expressed by the HSC-enriched population that did not correspond to any known gene or EST. This suggests that cells within the HSC population express a large number of completely novel transcripts, which is ϳ6% of all of the transcripts that they expressed. One caveat to these numbers is that some of the unidentified tags may identify the same transcript, although the number of transcripts with multiple tags would be expected to comprise only a small percentage of the tags detected.
Genes found to be differentially overexpressed by independent laboratories should be the highest priority candidate genes to additionally audition for key roles in HSC biology. Readers may use full databases (supplementary data) to perform their own meta-analyses, but to illustrate, we performed a limited meta-analysis of microarray results (50, 51 (11, 12) . Only the transcription factor GATA3 was overrepresented in all four datasets. Three transcription factors (HLF, MDS1, and CEBPB), one RNAprocessing protein (RBPMS/HERMES), and one cell surface receptor (MPL/CD110) were found in our own results plus two of the other datasets (Table 2) .
Recently, it has been proposed that cancer is a stem cell disease (2, (52) (53) (54) (55) (56) (57) . Most cancers may arise from self-renewing (stem) cells. Alternatively, cancer cells may mutationally gain certain characteristics of stem cells, particularly the ability to self-renew. A number of the genes identified in this study have already been implicated in ЈYESЈ signifies that the gene was overrepresented, ЈnoЈ that the genes was not overrepresented, and ЈNDЈ that the gene expression was not determined. b Genes marked with an asterisk (*) have been confirmed by real-time PCR. (Fig. S2) . c The average of the fold changes from BM, cord blood, and peripheral blood stem-progenitor cells. d Mouse side population cells from Table S3 of Ramalho-Santos et al. (11) . e Human fetal liver hematopoietic stem cell from Database S3 of Ivanova et al. (12) . f Mouse BM and fetal liver hematopoietic stem cell from Table S2 and Database S2 of Ivanova et al. (12) . g BM, bone marrow; SAGE, serial analysis of gene expression.
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on April 14, 2017. © 2004 American Association for Cancer cancerres.aacrjournals.org Downloaded from hematological malignancies; CD110/MPL is a good example. Overexpression of CD110 has been demonstrated to immortalize HSPCs. Finally, a number of studies have shown that leukemias arise from cells with HSC characteristics (2, 52, 53, 57) . Presumably, some of the other overexpressed genes, including the known and the newly identified genes maybe be involved in carcinogenesis, especially leukemogenesis. A number of studies have shown that at least some solid cancers are stem cell diseases. Hemmati et al. (55) found a subpopulation of brain tumor cells that resemble neural stem cells that appear to self-renew. Al-Hajj et al. (56) describe similar findings in breast tumors in that a protein expression-defined subset of tumor stem cells were the only cells able to reconstitute the tumor. Thus, identification of the full spectrum of genes involved in the biology of the HSCs is critically important for the study of leukemia and likely other cancers. Our rigorous examination of the transcriptomes of HSCs from all three of the major hematopoietic tissue sources should lead to identification of novel target genes involved in the development of hematopoietic and other malignancies.
